Vertex Pharmaceuticals Incorporated (VX1.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 10:41AM CEST. Market open.
| Previous close | 433.00 |
| Open | 436.50 |
| Bid | 436.50 x 10000 |
| Ask | 438.50 x 10000 |
| Day's range | 436.50 - 438.50 |
| 52-week range | 302.00 - 438.50 |
| Volume | |
| Avg. volume | 46 |
| Market cap | 113.819B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | 31.06 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Investor's Business Daily
Dow Jones Futures Fall As Growth Fears Mount; 7 Stocks Near Buy Points
The stock market was mixed Monday, but once again closed strong. Nvidia jumped while Meta and Spotify are stocks near buy points.
- GuruFocus.com
Insider Sale at Vertex Pharmaceuticals Inc (VRTX) by EVP, Chief Regulatory & Quality ...
On May 31, 2024, Ourania Tatsis, EVP, Chief Regulatory & Quality Officer of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), executed a sale of 4,600 shares of the company.
- Insider Monkey
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) the Leading Gene Therapy Stock to Buy Now?
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is the leading gene therapy stock to buy now. Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease. This approach […]
© 2024 Yahoo. All rights reserved.